MedTrace Logo

The Real World Study of Apatinib for Gastric Cancer Treatment in Anhui Province

NCT03333967 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 1000

Last updated 2017-11-07

No results posted yet for this study

Summary

The investigators conduct the real world study to explore the efficacy and safety of Apatinib in gastric cancer .

Conditions

Sponsors & Collaborators

  • The First Affiliated Hospital of Anhui Medical University

    lead OTHER

Principal Investigators

  • China Anhui · The First Affiliated Hospital of Anhui Medical University

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2017-09-01
Primary Completion
2019-09-01
Completion
2020-09-01

Countries

  • China

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03333967 on ClinicalTrials.gov